Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls

Mutagenesis

Volumn 27, Issue 2, 2012, Pages 225-232

  Slyskova, Jana ^a,b   Naccarati, Alessio ^a   Pardini, Barbara ^a   Polakova, Veronika ^a,b   Vodickova, Ludmila ^a,b,c   Smerhovsky, Zdenek ^b,c   Levy, Miroslav ^b   Lipska, Ludmila ^b   Liska, Vaclav ^b   Vodicka, Pavel ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; DNA; GLYCINE; LYSINE; MESSENGER RNA; VALINE; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; COLORECTAL CANCER; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE AND NUCLEOTIDE EXCISION REPAIR CAPACITY; EXCISION REPAIR; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84856833295     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger088     Document Type: Article

References (60)

1. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C. and Parkin, D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
2. Center, M. M., Jemal, A., Smith, R. A. and Ward, E. (2009) Worldwide variations in colorectal cancer. CA Cancer J. Clin., 59, 366-378.
3. Pritchard, C. C. and Grady, W. M. (2011) Colorectal cancer molecular biology moves into clinical practice. Gut, 60, 116-129.
4. de la Chapelle, A. (2004) Genetic predisposition to colorectal cancer. Nat. Rev. Cancer, 4, 769-780. (Pubitemid 39331149)
5. Giovannucci, E. and Michaud, D. (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology, 132, 2208-2225. (Pubitemid 46693749)
6. Botteri, E., Iodice, S., Bagnardi, V., Raimondi, S., Lowenfels, A. B. and Maisonneuve, P. (2008) Smoking and colorectal cancer: a meta-analysis. JAMA, 300, 2765-2778.
7. Tops, C. M., Wijnen, J. T. and Hes, F. J. (2009) Introduction to molecular and clinical genetics of colorectal cancer syndromes. Best Pract. Res. Clin. Gastroenterol, 23, 127-146.
8. Wu, X., Spitz, M. R., Amos, C. I. et al. (2006) Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res., 66, 5993-5996.
9. Mathers, J. C., Coxhead, J. M. and Tyson, J. (2007) Nutrition and DNA repair\-potential molecular mechanisms of action. Curr. Cancer Drug Targets, 7, 425-431. (Pubitemid 47196201)
10. Friedberg, E. C. (2001) How nucleotide excision repair protects against cancer. Nat. Rev. Cancer, 1, 22-33. (Pubitemid 33741878)
11. Schabath, M. B., Spitz, M. R., Grossman, H. B., Zhang, K., Dinney, C. P., Zheng, P. J. and Wu, X. (2003) Genetic instability in bladder cancer assessed by the comet assay. J. Natl. Cancer Inst., 95, 540-547. (Pubitemid 36511625)
12. Ramos, J. M., Ruiz, A., Colen, R., Lopez, I. D., Grossman, L. and Matta, J. L. (2004) DNA repair and breast carcinoma susceptibility in women. Cancer, 100, 1352-1357. (Pubitemid 38366837)
13. Shi, Q., Wang, L. E., Bondy, M. L., Brewster, A., Singletary, S. E. and Wei, Q. (2004) Reduced DNA repair of benzo[a]pyrene diol epoxidein-duced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis, 25, 1695-1700. (Pubitemid 39214312)
14. Pero, R. W., Miller, D. G., Lipkin, M., Markowitz, M., Gupta, S., Winawer, S. J., Enker, W. and Good, R. (1983) Reduced capacity for DNA repair synthesis in patients with or genetically predisposed to colorectal cancer. J. Natl. Cancer Inst., 70, 867-875. (Pubitemid 13101485)
15. Wei, Q., Lee, J. E., Gershenwald, J. E. et al. (2003) Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J. Natl. Cancer Inst., 95, 308-315. (Pubitemid 36336481)
16. Cheng, L., Eicher, S. A., Guo, Z., Hong, W. K., Spitz, M. R. and Wei, Q. (1998) Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prev., 7, 465-468. (Pubitemid 28354107)
17. Xiong, P., Hu, Z., Li, C., Wang, L. E., El-Naggar, A. K., Sturgis, E. M. and Wei, Q. (2007) In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck. Int. J. Cancer, 121, 2735-2740. (Pubitemid 350136420)
18. Wang, L. E., Hu, Z., Sturgis, E. M. et al. (2010) Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contrib-utes to risk of head and neck cancer but not tumor characteristics. Clin. Cancer Res., 16, 764-774.
19. Wei, Q., Matanoski, G. M., Farmer, E. R., Hedayati, M. A. and Grossman, L. (1995) DNA repair capacity for ultraviolet light-induced damage is reduced in peripheral lymphocytes from patients with basal cell carcinoma. J. Invest. Dermatol., 104, 933-936.
20. Wang, L. E., Li, C., Strom, S. S. et al. (2007) Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin. Cancer Res., 13, 6532-6539. (Pubitemid 350075045)
21. Wei, Q., Cheng, L., Amos, C. I., Wang, L. E., Guo, Z., Hong, W. K. and Spitz, M. R. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J. Natl. Cancer Inst., 92, 1764-1772.
22. Shen, H., Spitz, M. R., Qiao, Y., Guo, Z., Wang, L. E., Bosken, C. H., Amos, C. I. and Wei, Q. (2003) Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int. J. Cancer, 107, 84-88. (Pubitemid 37100089)
23. Orlow, I., Park, B. J., Mujumdar, U. et al. (2008) DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors. J. Clin. Oncol., 26, 3560-3566.
24. Deng, L., Kimmel, M., Foy, M., Spitz, M., Wei, Q. and Gorlova, O. (2009) Estimation of the effects of smoking and DNA repair capacity on coefficients of a carcinogenesis model for lung cancer. Int. J. Cancer, 124, 2152-2158.
25. Hu, J. J., Hall, M. C., Grossman, L., Hedayati, M., Mc Cullough, D. L., Lohman, K. and Case, L. D. (2004) Deficient nucleotide excision repair capacity enhanceshumanprostatecancerrisk. Cancer Res., 64, 1197-1201. (Pubitemid 38176929)
26. Bustin, S. A., Benes, V., Garson, J. A. et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem., 55, 611-622.
27. Friedberg, E. C. (2006) DNA Repair and Mutagenesis. 2nd edn. ASM Press, Washington, DC.
28. Vodicka, P., Stetina, R., Polakova, V. et al. (2007) Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis, 28, 657-664. (Pubitemid 46523361)
29. Hu, Z., Wang, Y., Wang, X. et al. (2005) DNA repair gene XPC genotypes/ haplotypes and risk of lung cancer in a Chinese population. Int. J. Cancer, 115, 478-483. (Pubitemid 40663754)
30. Jernstrom, B. and Graslund, A. (1994) Covalentbinding ofbenzo[a]pyrene 7,8-dihydrodiol 9,10-epoxides to DNA: molecular structures, induced mutations and biological consequences. Biophys. Chem., 49, 185-199.
31. Gillet, L. C. and Scharer, O. D. (2006) Molecular mechanisms of mammalian global genome nucleotide excision repair. Chem. Rev., 106, 253-276.
32. Carvajal-Carmona, L. G. (2010) Genetic dissection of intermediate phenotypes as a way to discover novel cancer susceptibility alleles. Curr. Opin. Genet. Dev., 20, 308-314.
33. Alexandrov, K., Rojas, M., Kadlubar, F. F., Lang, N. P. and Bartsch, H. (1996) Evidence of anti-benzo[a]pyrene diol epoxide-DNA adduct forma-tion in human colon mucosa. Carcinogenesis, 17, 2081-2083. (Pubitemid 26325408)
34. Helleday, T., Petermann, E., Lundin, C., Hodgson, B. and Sharma, R. A. (2008) DNA repair pathways as targets for cancer therapy. Nat. Rev. Cancer, 8, 193-204. (Pubitemid 351301852)
35. Martin, L. P., Hamilton, T. C. and Schilder, R. J. (2008) Platinum resistance: the role of DNA repair pathways. Clin. Cancer Res., 14, 1291-1295. (Pubitemid 351413906)
36. Center, M. M., Jemal, A. and Ward, E. (2009) International trends in colorectal cancer incidence rates. Cancer Epidemiol. Biomarkers Prev., 18, 1688-1694.
37. Slyskova, J., Naccarati, A., Polakova, V. et al. (2011) DNA damage and nucleotide excision repair capacity in healthy individuals. Environ. Mol. Mutagen, 52, 511-517.
38. Collins, A. R. (2004) The comet assay for DNA damage and repair: principles, applications, and limitations. Mol. Biotechnol., 26, 249-261. (Pubitemid 41490465)
39. Collins, A. R., Dusinska, M., Gedik, C. M. and Stetina, R. (1996) Oxidative damage to DNA: do we have a reliable biomarker? Environ. Health Perspect., 104 (Suppl. 3), 465-469. (Pubitemid 26197677)
40. Collins, A. R., Oscoz, A. A., Brunborg, G., Gaivao, I., Giovannelli, L., Kruszewski, M., Smith, C. C. and Stetina, R. (2008) The comet assay: topical issues. Mutagenesis, 23, 143-151.
41. Moller, P. (2006) Assessment of reference values for DNA damage detected by the comet assay in human blood cell DNA. Mutat Res., 612, 84-104. (Pubitemid 43222095)
42. Mc Kenna, D. J., Mc Keown, S. R. and Mc Kelvey-Martin, V. J. (2008) Potential use of the comet assay in the clinical management of cancer. Mutagenesis, 23, 183-190.
43. Paz-Elizur, T., Sevilya, Z., Leitner-Dagan, Y., Elinger, D., Roisman, L. C. and Livneh, Z. (2008) DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention. Cancer Lett., 266, 60-72.
44. Collins, A. R. and Gaivao, I. (2007) DNA base excision repair as a biomarker in molecular epidemiology studies. Mol. Aspects Med., 28, 307-322. (Pubitemid 47331612)
45. Park, C. J. and Choi, B. S. (2006) The protein shuffle. Sequential interactions among components of the human nucleotide excision repair pathway. FEBS J., 273, 1600-1608.
46. Araujo, S. J., Nigg, E. A. and Wood, R. D. (2001) Strong functional interactions of TFIIH with XPC and XPG in human DNA nucleotide excision repair, without a preassembled repairosome. Mol. Cell Biol., 21, 2281-2291. (Pubitemid 32222082)
47. Vogel, U., Dybdahl, M., Frentz, G. and Nexo, B. A. (2000) DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to m RNA levels in primary lymphocytes. Mutat. Res., 461, 197-210.
48. Stevens, E. V., Nishizuka, S., Antony, S. et al. (2008) Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers. Mol. Cancer Ther., 7, 10-18.
49. Damia, G., Guidi, G. and D'Incalci, M. (1998) Expression of genes involved in nucleotide excision repair and sensitivity to cisplatin and melphalan in human cancer cell lines. Eur. J. Cancer, 34, 1783-1788. (Pubitemid 28474236)
50. Hanova, M., Stetina, R., Vodickova, L. et al. (2011) Modulation of DNA repair capacity and m RNA expression levels of XRCC1, h OGG1 and XPC genes in styrene-exposed workers. Toxicol. Appl. Pharmacol., 248, 194-200.
51. Cheung, V. G. and Spielman, R. S. (2009) Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat. Rev. Genet., 10, 595-604.
52. Chang, Y. C., Jan, K. Y., Cheng, C. A., Liao, C. B. and Liu, Y. C. (2008) Direct involvement of the tumor suppressor p53 in nucleotide excision repair. DNA Repair (Amst), 7, 751-761.
53. Francisco, G., Menezes, P. R., Eluf-Neto, J. and Chammas, R. (2008) XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur. J. Hum. Genet., 16, 724-734. (Pubitemid 351753369)
54. Qiu, L., Wang, Z. and Shi, X. (2008) Associations between XPC polymorphisms and risk of cancers: a meta-analysis. Eur. J. Cancer, 44, 2241-2253.
55. Naccarati, A., Pardini, B., Hemminki, K. and Vodicka, P. (2007) Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat. Res., 635, 118-145. (Pubitemid 46756400)
56. Pardini, B., Naccarati, A., Novotny, J. et al. (2008) DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat. Res., 638, 146-153.
57. Tomlinson, I., Houlston, R., Montgomery, G., Sieber, O. and Dunlop, M. (2012) Investigation of the effects of DNA repair gene polymorphisms on the risk ofcolorectal cancer. Mutagenesis, 27, 219-223.
58. Friedberg, E. C. (1987)Themolecularbiologyofnucleotideexcisionrepair of DNA: recent progress. J. Cell. Sci. Suppl., 6, 1-23.
59. Collins, A. R. and Azqueta, A. (2011) DNA repair as a biomarker in human biomonitoring studies; further applications of the comet assay. Mutat. Res. Fundam. Mol. Mech. Mugag. Apr 1 2011 [Epub ahead of print].
60. Dusinska, M. and Collins, A. R. (2008) The comet assay in human biomonitoring: gene-environment interactions. Mutagenesis, 23, 191-205.